{"id":473,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","title":{"rendered":"LL-37 Evidenzgrenzen: Endogenes Peptid, technische Lieferung und Katalogmaterial"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">\u201eLL-37\u201c kann sich auf ein endogenes menschliches Abwehrpeptid, ein synthetisches Testreagenz oder ein technisches biologisches Abgabesystem beziehen. Ergebnisse einer dieser Interventionen k\u00f6nnen nicht automatisch auf eine andere \u00fcbertragen werden.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Was die Aufzeichnung zeigt<\/h2><ul class=\"wp-block-list\"><li>Die endogene Expression ist kein Beweis f\u00fcr eine exogene Verabreichung.<\/li><li>Ein manipulierter Organismus, der LL-37 exprimiert, ist nicht gleichbedeutend mit isoliertem synthetischem LL-37.<\/li><li>FDA meldet unzureichende Informationen zur menschlichen Sicherheit und weist auf Bedenken hinsichtlich Immunogenit\u00e4t, Fortpflanzung und gewebespezifischer Tumore hin.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png\" alt=\"Wissenschaftler \u00fcberpr\u00fcft Bakterientests und Peptidmembran-Forschungsdaten\" class=\"wp-image-461\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Originale redaktionelle Illustration zur Identifizierung des Forschungsthemas. Es stellt keine Katalogcharge, kein zugelassenes Medikament, kein Testergebnis oder keine klinische Verwendung dar.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Die Identit\u00e4ts- und Beweisgrenze<\/h2><p class=\"wp-block-paragraph\">Ein Artikel \u00fcber einen LL-37-exprimierenden Mikroorganismus testet den gesamten technischen Eingriff, einschlie\u00dflich seines Abgabesystems. Es sollte nicht so dargestellt werden, als ob die Teilnehmer ein Fl\u00e4schchen mit isoliertem LL-37 erhalten h\u00e4tten.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Endogener Kontext<\/strong><span>Menschliches Cathelicidin in der angeborenen Immunit\u00e4t<\/span><\/div><div class=\"pim-evidence-row\"><strong>Assay-Kontext<\/strong><span>Synthetisches Peptid unter spezifizierten In-vitro-Bedingungen<\/span><\/div><div class=\"pim-evidence-row\"><strong>Sicherheitskontext<\/strong><span>FDA identifiziert gro\u00dfe Informationsl\u00fccken und nichtklinische Bedenken<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Was in die Materialakte geh\u00f6rt<\/h2><p class=\"wp-block-paragraph\">Zur Materialcharakterisierung beantworten Sequenzbest\u00e4tigung, Reinheit, Masse, Aggregation und Endotoxin- oder Keimbelastungskontrollen unterschiedliche Fragen. Keiner liefert eine Schlussfolgerung zur menschlichen Wirksamkeit.<\/p><h2 class=\"wp-block-heading\">Redaktionelle Regel<\/h2><p class=\"wp-block-paragraph\">Verwenden Sie den genauen Interventionsnamen, das Modell, die Population und den Endpunkt aus dem zitierten Datensatz. Wandeln Sie eine Assoziation, einen Mechanismus, ein Tierergebnis, eine genehmigte Fertigarzneimittelaufzeichnung oder einen analytischen Test nicht in einen Anspruch \u00fcber eine nicht verwandte Katalogcharge um.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u201eLL-37\u201c kann sich auf ein endogenes menschliches Abwehrpeptid, ein synthetisches Testreagenz oder ein technisches biologisches Abgabesystem beziehen. Ergebnisse einer dieser Interventionen k\u00f6nnen nicht automatisch auf eine andere \u00fcbertragen werden.<\/p>","protected":false},"author":1,"featured_media":638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"348","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"In-vitro evidence and current FDA safety assessment","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"LL-37 ocular expression and antimicrobial activity\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16020269\/\",\"note\":\"Human tissue expression and in-vitro assays; PMID 16020269.\"},{\"title\":\"LL-37 analog activity, cytotoxicity and serum inhibition\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15980359\/\",\"note\":\"In-vitro context; PMID 15980359.\"},{\"title\":\"FDA list of bulk substances with significant safety concerns\",\"url\":\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"note\":\"Current FDA LL-37 safety summary.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LL-37 Evidence Boundaries: Endogenous vs Engineered<\/title>\n<meta name=\"description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\" \/>\n<meta property=\"og:description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"name\":\"LL-37 Evidence Boundaries: Endogenous vs Engineered\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LL-37 Evidenzgrenzen: Endogen vs. k\u00fcnstlich","description":"\u201eLL-37\u201c kann sich auf ein endogenes menschliches Abwehrpeptid, ein synthetisches Testreagenz oder ein technisches biologisches Abgabesystem beziehen. Ergebnisse von einem dieser\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_locale":"de_DE","og_type":"article","og_title":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","og_description":"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026","og_url":"https:\/\/nhdbio.com\/de\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","url":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","name":"LL-37 Evidenzgrenzen: Endogen vs. k\u00fcnstlich","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"\u201eLL-37\u201c kann sich auf ein endogenes menschliches Abwehrpeptid, ein synthetisches Testreagenz oder ein technisches biologisches Abgabesystem beziehen. Ergebnisse von einem dieser\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=473"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/473\/revisions"}],"predecessor-version":[{"id":503,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/473\/revisions\/503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/638"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}